Article info

Original research
Comparing vision and macular thickness in neovascular age-related macular degeneration, diabetic macular oedema and retinal vein occlusion patients treated with intravitreal antivascular endothelial growth factor injections in clinical practice

Authors

  1. Correspondence to Dr Rajya L Gurung; rajyalaxmi.gurung{at}utas.edu.au
View Full Text

Citation

Gurung RL, FitzGerald LM, McComish BJ, et al
Comparing vision and macular thickness in neovascular age-related macular degeneration, diabetic macular oedema and retinal vein occlusion patients treated with intravitreal antivascular endothelial growth factor injections in clinical practice

Publication history

  • Received February 22, 2021
  • Revised March 17, 2021
  • Accepted April 24, 2021
  • First published May 3, 2021.
Online issue publication 
May 03, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.